ST南新(688189)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688189 ST南新

已收盘 11-04 15:00:00

{"stockData":{"symbol":"688189","market":"SH","secType":"STK","nameCN":"ST南新","latestPrice":6.01,"timestamp":1793775600000,"preClose":5.97,"halted":0,"volume":1798533,"delay":0,"changeRate":0.0067,"floatShares":273000000,"shares":273000000,"eps":-0.4814,"marketStatus":"已收盘","change":0.04,"latestTime":"11-04 15:00:00","open":5.95,"high":6.02,"low":5.89,"amount":10716800,"amplitude":0.0218,"askPrice":6.01,"askSize":66,"bidPrice":6,"bidSize":203,"shortable":0,"etf":0,"ttmEps":-0.4814,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793842200000},"marketStatusCode":5,"adr":0,"adjPreClose":5.97,"symbolType":"stock_kcb","openAndCloseTimeList":[[1793755800000,1793763000000],[1793768400000,1793775600000]],"highLimit":6.27,"lowLimit":5.67,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":272829414,"isCdr":false,"pbRate":2.17,"roa":"--","roe":"--","epsLYR":-0.4989,"committee":0.13012,"marketValue":1640000000,"turnoverRate":0.0066,"status":0,"afterMarket":{"amount":0,"volume":0,"close":6.01,"buyVolume":3000,"sellVolume":0,"time":1793777637746,"indexStatus":"已收盘 11-04 15:30:00","preClose":5.97},"floatMarketCap":1640000000},"requestUrl":"/m/hq/s/688189","defaultTab":"news","newsList":[{"id":"2680272307","title":"ST南新（688189）2026年三季报简析：营收上升亏损收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=2680272307","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680272307?lang=zh_cn&edition=full","pubTime":"2026-11-01 06:26","pubTimestamp":1793485583,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期ST南新发布2026年三季报。根据财报显示，ST南新营收上升亏损收窄。截至本报告期末，公司营业总收入9218.34万元，同比上升10.86%，归母净利润-6306.56万元，同比上升8.11%。按单季度数据看，第三季度营业总收入3613.87万元，同比上升69.6%，第三季度归母净利润-2590.39万元，同比上升9.53%。本次财报公布的各项数据指标表现尚佳。本文数据来源于ST南新2026年三季报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110100001438.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679524909","title":"图解ST南新三季报：第三季度单季净利润同比增长9.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679524909","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679524909?lang=zh_cn&edition=full","pubTime":"2026-10-31 00:50","pubTimestamp":1793379044,"startTime":"0","endTime":"0","summary":"证券之星消息，ST南新2026年三季报显示，前三季度公司主营收入9218.34万元，同比上升10.86%；归母净利润-6306.56万元，同比上升8.11%；扣非净利润-5937.11万元，同比上升10.71%；其中2026年第三季度，公司单季度主营收入3613.87万元，同比上升69.6%；单季度归母净利润-2590.39万元，同比上升9.53%；单季度扣非净利润-2350.78万元，同比上升5.06%；负债率17.24%，财务费用-62.43万元，毛利率19.31%。财报数据概要请见下图:本文数据来源于ST南新2026年三季报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100003298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679034216","title":"ST南新（688189）披露2026年第三季度报告，10月30日股价下跌1.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679034216","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679034216?lang=zh_cn&edition=full","pubTime":"2026-10-30 19:53","pubTimestamp":1793361190,"startTime":"0","endTime":"0","summary":"截至2026年10月30日收盘，ST南新报收于5.76元，较前一交易日下跌1.71%，最新总市值为15.71亿元。该股当日开盘5.84元，最高5.98元，最低5.75元，成交额达751.72万元，换手率为0.47%。近日，湖南南新制药股份有限公司披露《2026年第三季度报告》。报告显示，本报告期营业收入为36,138,703.49元，同比增长69.60%；归属于上市公司股东的净利润为-25,903,911.43元。年初至报告期末营业收入为92,183,395.23元，同比增长10.86%；归属于上市公司股东的净利润为-63,065,568.01元。研发投入合计为33,980,066.99元，同比下降40.13%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000049982.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688189","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679218027","title":"ST南新(688189)9月30日股东户数0.87万户，较上期减少0.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679218027","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679218027?lang=zh_cn&edition=full","pubTime":"2026-10-30 19:11","pubTimestamp":1793358681,"startTime":"0","endTime":"0","summary":"证券之星消息，近日ST南新披露，截至2026年9月30日公司股东户数为8714.0户，较9月10日减少42.0户，减幅为0.48%。在化学制药行业个股中，ST南新股东户数低于行业平均水平，截至9月30日，化学制药行业平均股东户数为3.98万户。从股价来看，2026年9月10日至2026年9月30日，ST南新区间跌幅为2.13%，在此期间股东户数减少42.0户，减幅为0.48%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000046510.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679647981","title":"虚增利润占157%，ST南新预罚单落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2679647981","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679647981?lang=zh_cn&edition=full","pubTime":"2026-10-29 17:11","pubTimestamp":1793265060,"startTime":"0","endTime":"0","summary":"公司股票自6月11日起被实施其他风险警示，证券简称变更为ST南新。两项合计，2023年公司虚增营收6468.28万元、占当期营业收入的8.69%；虚增利润总额1195.22万元、占当期利润总额的157.11%——也就是说，当年账面利润全部由造假“贡献”。刘佳律师指出，公司困境还不止于此：筹划近两个月的现金收购于2025年10月宣告终止，第二大股东同步抛出减持计划；2025年上半年公司营业收入不足亿元，仅为上年同期的28.7%，转型故事与财务真实性同时承压。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2026-10-29/doc-iniwwtux5274075.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688189","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677134946","title":"ST南新（688189）10月23日主力资金净卖出122.61万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677134946","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677134946?lang=zh_cn&edition=full","pubTime":"2026-10-23 15:26","pubTimestamp":1792740415,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月23日收盘，ST南新报收于5.92元，下跌0.67%，换手率1.26%，成交量3.45万手，成交额2012.6万元。ST南新主营业务：专注于抗感染、呼吸系统和心脑血管等疾病领域药品的研发、生产与销售的制药。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300023046.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674855833","title":"ST南新(688189.SH)：使用不超2亿元闲置募集资金临时补充流动资金","url":"https://stock-news.laohu8.com/highlight/detail?id=2674855833","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674855833?lang=zh_cn&edition=full","pubTime":"2026-10-09 18:17","pubTimestamp":1791541022,"startTime":"0","endTime":"0","summary":"格隆汇10月9日丨ST南新(688189.SH)公布，公司于2026年9月28日召开第三届董事会审计委员会2026年第一次会议、于2026年10月9日召开第三届董事会第二次会议，审议通过了《关于使用部分闲置募集资金暂时补充流动资金的议案》，同意公司使用不超过人民币20,000.00万元(含本数)闲置募集资金临时补充流动资金，并仅限用于公司的业务拓展、日常经营等与主营业务相关的生产经营活动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20261009/32391881.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","688189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669079129","title":"股市必读：ST南新制药新发布《第三届董事会第一次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2669079129","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669079129?lang=zh_cn&edition=full","pubTime":"2026-09-23 02:13","pubTimestamp":1790100789,"startTime":"0","endTime":"0","summary":"公司公告汇总：公司完成董事会换届选举，李智诚当选第三届董事会董事长并任法定代表人；彭程任总经理，袁超龙任财务总监，李旋任董事会秘书。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300002550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","01477","BK0239","688189","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669123407","title":"ST南新(688189.SH)：核心技术人员张世喜离职","url":"https://stock-news.laohu8.com/highlight/detail?id=2669123407","media":"中金财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669123407?lang=zh_cn&edition=full","pubTime":"2026-09-22 23:27","pubTimestamp":1790090822,"startTime":"0","endTime":"0","summary":"格隆汇9月22日丨ST南新(688189.SH)公布，公司核心技术人员张世喜先生因工作调整原因申请离职，并于近日办理完成离职手续。离职后，张世喜先生将不在公司及子公司担任任何职务。\n\n　　张世喜先生在公司任职及担任核心技术人员期间，参与研发的知识产权所有权均归属于公司或子公司，不存在涉及职务成果、知识产权相关的纠纷或潜在纠纷的情形，也不存在影响公司知识产权完整性的情况。\n\n　　张世喜先生负责的工作已完成交接，公司的生产经营、技术研发等工作均正常开展，本次核心技术人员离职不会对公司持续经营能力、研发实力及核心竞争力产生重大不利影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260922/32378307.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","688189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669288561","title":"ST南新（688189）披露提前归还募集资金公告，9月22日股价下跌0.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669288561","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669288561?lang=zh_cn&edition=full","pubTime":"2026-09-22 22:19","pubTimestamp":1790086754,"startTime":"0","endTime":"0","summary":"截至2026年9月22日收盘，ST南新报收于6.62元，较前一交易日下跌0.75%，最新总市值为18.06亿元。该股当日开盘6.65元，最高6.7元，最低6.55元，成交额达2204.87万元，换手率为1.22%。近日，湖南南新制药股份有限公司发布《关于提前归还临时用于补充流动资金的募集资金的公告》。该笔资金原计划使用期限为2025年10月29日至2026年10月28日，现提前归还。公司已通知保荐机构及保荐代表人。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200041718.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666583035","title":"破发股ST南新跌2.93% 2020年上市募12亿西部证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2666583035","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666583035?lang=zh_cn&edition=full","pubTime":"2026-09-09 15:54","pubTimestamp":1788940443,"startTime":"0","endTime":"0","summary":"中国经济网北京9月9日讯 ST南新 今日收报6.63元，跌幅2.93%。目前该股处于破发状态。A股股票简称由“南新制药”变更为“ST南新”；扩位简称由“南新制药”变更为“ST南新制药”，实施其他风险警示的起始日为2026年6月11日。　　南新制药于2020年3月26日在上交所科创板上市，发行价格为34.94元/股，首次公开发行新股3500万股，保荐机构为西部证券股份有限公司，保荐代表人为李锋、邹扬。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260909/32364700.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0183","BK0239","BK0276","688189","BK0028","IPOS","BK0188","002673"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665367857","title":"股市必读：ST南新新发布《2026年9月2日投资者关系活动记录表》","url":"https://stock-news.laohu8.com/highlight/detail?id=2665367857","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665367857?lang=zh_cn&edition=full","pubTime":"2026-09-07 01:33","pubTimestamp":1788715988,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，ST南新报收于6.71元，上涨0.0%，换手率1.18%，成交量3.23万手，成交额2176.23万元。当日关注点交易信息汇总：9月4日主力资金净流入101.59万元，占总成交额4.67%。公司公告汇总：帕拉米韦吸入溶液III期临床已达主要终点，正推进上市申报前沟通，预计审核周期12–18个月。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700000785.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665366568","title":"每周股票复盘：ST南新（688189）转让应收款5175.67万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2665366568","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665366568?lang=zh_cn&edition=full","pubTime":"2026-09-06 03:22","pubTimestamp":1788636131,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，ST南新报收于6.71元，较上周的6.62元上涨1.36%。本周，ST南新9月2日盘中最高价报6.96元。本周关注点来自公司公告汇总：公司转让部分应收账款给控股股东，收回转让款5175.67万元。公司通过公开挂牌程序，将部分应收账款转让给控股股东湖南医药发展投资集团有限公司，转让价款为5,175.67万元。控股股东已全额支付应收账款转让款5175.67万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600001120.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664810788","title":"ST南新（688189）披露股东减持股份计划公告，9月2日股价下跌0.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664810788","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664810788?lang=zh_cn&edition=full","pubTime":"2026-09-02 23:04","pubTimestamp":1788361465,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘，ST南新报收于6.86元，较前一交易日下跌0.29%，最新总市值为18.72亿元。近日，ST南新披露《股东减持股份计划公告》。公告显示，截至2026年9月3日，公司股东广州乾元持有公司股份43,120,000股，占总股本的15.80%。因资金需求，广州乾元拟于2026年9月28日至12月25日期间，通过集中竞价和大宗交易方式减持不超过8,184,882股，即不超过公司总股本的3.00%。本次减持计划不会导致公司控制权变更。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200043482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664890748","title":"ST南新(688189.SH)：广州乾元拟减持不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2664890748","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664890748?lang=zh_cn&edition=full","pubTime":"2026-09-02 17:36","pubTimestamp":1788341789,"startTime":"0","endTime":"0","summary":"智通财经APP讯，ST南新(688189.SH)发布公告，因资金需求，广州乾元投资咨询合伙企业(有限合伙)(简称“广州乾元”)拟通过集中竞价交易和大宗交易方式减持其所持有的公司股份，在减持计划披露之日起十五个交易日后的三个月内进行，合计减持股份数量不超过818.49万股，不超过公司总股本的3%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490994.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663709930","title":"ST南新（688189）披露2026年半年度报告，8月31日股价上涨1.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663709930","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663709930?lang=zh_cn&edition=full","pubTime":"2026-08-31 19:29","pubTimestamp":1788175784,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，ST南新报收于6.74元，较前一交易日上涨1.81%，最新总市值为18.39亿元。公司于近日披露《2026年半年度报告》。公告显示，湖南南新制药股份有限公司2026年半年度报告摘要中，公司总资产为854,407,608.70元，较上年度末增长5.55%；归属于上市公司股东的净资产为780,521,594.01元，较上年度末减少0.39%。本期营业收入为56,044,691.74元，同比下降9.38%；利润总额为-40,993,615.57元，归属于上市公司股东的净利润为-37,161,656.58元，亏损同比收窄。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100031207.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688189","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663789580","title":"ST南新：聘任彭程先生为公司总经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2663789580","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663789580?lang=zh_cn&edition=full","pubTime":"2026-08-31 15:33","pubTimestamp":1788161625,"startTime":"0","endTime":"0","summary":"证券之星消息，ST南新(688189)08月31日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，公司近期人事是否有变动？ST南新回复：尊敬的投资者您好，公司近期完成总经理聘任工作，经董事会审议通过，聘任彭程先生为公司总经理，相关事项已对外披露。本次属于公司正常经营层面人事安排，不会对公司生产经营产生不利影响，管理层相关信息请以公司公开公告为准。感谢关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100015539.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688189","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663786040","title":"ST南新：截至2026年8月20日，公司股东总户数为8873户","url":"https://stock-news.laohu8.com/highlight/detail?id=2663786040","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663786040?lang=zh_cn&edition=full","pubTime":"2026-08-31 15:33","pubTimestamp":1788161625,"startTime":"0","endTime":"0","summary":"证券之星消息，ST南新(688189)08月31日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止8月20日，股东户数是多少？谢谢！ST南新回复：尊敬的投资者您好，根据中国证券登记结算有限责任公司提供的数据，截至2026年8月20日，公司股东总户数为8873户。感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100015537.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663602973","title":"ST南新2026年半年报：新药研发获进展，亏损幅度收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=2663602973","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663602973?lang=zh_cn&edition=full","pubTime":"2026-08-31 11:13","pubTimestamp":1788146034,"startTime":"0","endTime":"0","summary":"蓝鲸新闻8月31日讯，8月30日，ST南新 公布2026年中报，公司依托抗感染与呼吸系统领域核心产品，受制于医药行业集采深化及市场竞争加剧，报告期业绩持续承压但亏损幅度收窄；同时，改良型新药研发取得里程碑进展，并通过向控股股东转让应收账款优化资产结构。截至报告期末，公司总资产8.54亿元，较上年度末增长5.55%，主要系新增银行贷款及往来款项增加。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1788143016716096258","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["688189","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663049078","title":"图解ST南新中报：第二季度单季净利润同比增长25.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663049078","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663049078?lang=zh_cn&edition=full","pubTime":"2026-08-30 17:39","pubTimestamp":1788082795,"startTime":"0","endTime":"0","summary":"证券之星消息，ST南新2026年中报显示，上半年度公司主营收入5604.47万元，同比下降9.38%；归母净利润-3716.17万元，同比上升7.1%；扣非净利润-3586.34万元，同比上升14.06%；其中2026年第二季度，公司单季度主营收入2999.58万元，同比上升41.35%；单季度归母净利润-2391.81万元，同比上升25.2%；单季度扣非净利润-2241.11万元，同比上升32.99%；负债率16.91%，财务费用-35.98万元，毛利率15.0%。财报数据概要请见下图:本文数据来源于ST南新2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000012890.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688189"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793828131237,"stockEarnings":[{"period":"1week","weight":0.0152},{"period":"1month","weight":-0.0668},{"period":"3month","weight":-0.074},{"period":"6month","weight":-0.3163},{"period":"1year","weight":-0.3467},{"period":"ytd","weight":-0.2459}],"compareEarnings":[{"period":"1week","weight":0.0013},{"period":"1month","weight":-0.0406},{"period":"3month","weight":-0.0549},{"period":"6month","weight":-0.1181},{"period":"1year","weight":-0.0692},{"period":"ytd","weight":-0.0712}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"湖南南新制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"8714人(较上一季度减少0.48%)","perCapita":"31309股","listingDate":"2020-03-26","address":"湖南省长沙市浏阳市经济技术开发区康里路1号","registeredCapital":"27282万元","survey":"　　湖南南新制药股份有限公司的主营业务是抗感染、呼吸系统和心脑血管等疾病领域药品的研发、生产与销售。公司的主要产品是帕拉米韦氯化钠注射液、磷酸奥司他韦干混悬剂、辛伐他汀分散片、阿托伐他汀钙片、贝那普利氢氯噻嗪片、头孢呋辛酯分散片、头孢克洛胶囊、头孢克洛干混悬剂、乳酸环丙沙星氯化钠注射液、布洛芬混悬滴剂、布洛芬混悬液、盐酸美金刚缓释胶囊。","listedPrice":34.94},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ST南新(688189)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ST南新(688189)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ST南新,688189,ST南新股票,ST南新股票老虎,ST南新股票老虎国际,ST南新行情,ST南新股票行情,ST南新股价,ST南新股市,ST南新股票价格,ST南新股票交易,ST南新股票购买,ST南新股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ST南新(688189)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ST南新(688189)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}